Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 34 results.
User Information
Export Records
  1. 1.   SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
  2. Joyce, M. Gordon; Chen, Wei-Hung; Sankhala, Rajeshwer S.; Hajduczki, Agnes; Thomas, Paul; Choe, Misook; Martinez, Elizabeth J.; Chang, William C.; Peterson, Caroline E.; Morrison, Elaine B.; Smith,Clayton; Chen, Rita E.; Ahmed, Aslaa; Wieczorek, Lindsay; Anderson, Alexander; Case, James Brett; Li, Yifan; Oertel, Therese; Rosado, Lorean; Ganesh, Akshaya; Whalen, Connor; Carmen, Joshua M.; Mendez-Rivera, Letzibeth; Karch, Christopher P.; Gohain, Neelakshi; Villar, Zuzana; McCurdy, David; Beck, Zoltan; Kim, Jiae; Shrivastava, Shikha; Jobe, Ousman; Dussupt, Vincent; Molnar, Sebastian; Tran, Ursula; Kannadka, Chandrika B.; Soman, Sandrine; Kuklis, Caitlin; Zemil, Michelle; Khanh, Htet; Wu,Weimin; Cole, Matthew A.; Duso, Debra K.; Kummer, Larry W.; Lang, Tricia J.; Muncil, Shania E.; Currier, Jeffrey R.; Krebs, Shelly J.; Polonis, Victoria R.; Rajan, Saravanan; McTamney, Patrick M.; Esser, Mark T.; Reiley, William W.; Rolland, Morgane; de Val, Natalia; Diamond, Michael S.; Gromowski, Gregory D.; Matyas, Gary R.; Rao, Mangala; Michael, Nelson L.; Modjarrad, Kayvon
  3. CELL REPORTS. 2021, DEC 21; 37(12):
  1. 2.   Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge
  2. Felber,Barbara; Lu, Zhongyan; Hu, Xintao; Valentin,Antonio; Rosati,Margherita; Remmel, Christopher A L; Weiner, Joshua A; Carpenter, Margaret C; Faircloth, Katelyn; Stanfield-Oakley, Sherry; Williams, Wilton B; Shen, Xiaoying; Tomaras, Georgia D; LaBranche, Celia C; Montefiori, David; Trinh, Hung V; Rao, Mangala; Alam, Munir S; Vandergrift, Nathan A; Saunders, Kevin O; Wang, Yunfei; Rountree, Wes; Das, Jishnu; Alter, Galit; Reed, Steven G; Aye, Pyone P; Schiro, Faith; Pahar, Bapi; Dufour, Jason P; Veazey, Ronald S; Marx, Preston A; Venzon, David J; Shaw, George M; Ferrari, Guido; Ackerman, Margaret E; Haynes, Barton F; Pavlakis,George
  3. Cell reports. 2020, May 12; 31(6): 107624.
  1. 3.   SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses
  2. Lai, L. L.; Kwa, S. F.; Kozlowski, P. A.; Montefiori, D. C.; Nolen, T. L.; Hudgens, M. G.; Johnson, W. E.; Ferrari, G.; Hirsch, V. M.; Felber, B. K.; Pavlakis, G. N.; Earl, P. L.; Moss, B.; Amara, R. R.; Robinson, H. L.
  3. Vaccine. 2012, Feb; 30(9): 1737-1745.
  1. 4.   Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections
  2. Gnanakaran, S.; Bhattacharya, T.; Daniels, M.; Keele, B. F.; Hraber, P. T.; Lapedes, A. S.; Shen, T. Y.; Gaschen, B.; Krishnamoorthy, M.; Li, H.; Decker, J. M.; Salazar-Gonzalez, J. F.; Wang, S. Y.; Jiang, C. L.; Gao, F.; Swanstrom, R.; Anderson, J. A.; Ping, L. H.; Cohen, M. S.; Markowitz, M.; Goepfert, P. A.; Saag, M. S.; Eron, J. J.; Hicks, C. B.; Blattner, W. A.; Tomaras, G. D.; Asmal, M.; Letvin, N. L.; Gilbert, P. B.; DeCamp, A. C.; Magaret, C. A.; Schief, W. R.; Ban, Y. E. A.; Zhang, M.; Soderberg, K. A.; Sodroski, J. G.; Haynes, B. F.; Shaw, G. M.; Hahn, B. H.; Korber, B.
  3. Plos Pathogens. 2011, Sep; 7(9): 19.
  1. 5.   Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals
  2. Ho, J.; Moir, S.; Wang, W.; Posada, J. G.; Gu, W. J.; Rehman, M. T.; Dewar, R.; Kovacs, C.; Sneller, M. C.; Chun, T. W.; Follmann, D. A.; Fauci, A. S.
  3. Aids. 2011, Jan; 25(3): 295-302.
  1. 6.   A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation
  2. Vagenas, P.; Aravantinou, M.; Williams, V. G.; Jasny, E.; Piatak, M.; Lifson, J. D.; Salazar, A. M.; Blanchard, J. L.; Gettie, A.; Robbiani, M.
  3. Plos One. 2010, Sep; 5(9): 13.
  1. 7.   FDA guidance on prophylactic DNA vaccines: Analysis and recommendations
  2. Klinman, D. M.; Klaschik, S.; Tross, D.; Shirota, H.; Steinhagen, F.
  3. Vaccine. 2010, Apr; 28(16): 2801-2805.
  1. 8.   Tonsillar Application of AT-2 SIV Affords Partial Protection Against Rectal Challenge With SIVmac239
  2. Vagenas, P.; Williams, V. G.; Piatak, M.; Bess, J. W.; Lifson, J. D.; Blanchard, J. L.; Gettie, A.; Robbiani, M.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2009 52(4): 433-442.
  1. 9.   Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV89.6P challenge in rhesus macaques
  2. Chong, S. Y.; Egan, M. A.; Kutzler, M. A.; Megati, S.; Masood, A.; Roopchard, V.; Garcia-H, D.; Montefiori, D. C.; Quiroz, J.; Rosati, M.; Schadeck, E. B.; Boyer, J. D.; Pavlakis, G. N.; Weiner, D. B.; Sidhu, M.; Eldridge, J. H.; Israel, Z. R.
  3. Vaccine. 2007, Jun; 25(26): 4967-4982.
  1. 10.   Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques
  2. Luckay, A.; Sidhu, M. K.; Kjeken, R.; Megati, S.; Chong, S. Y.; Roopch, V.; Garcia-H, D.; Abdullah, R.; Braun, R.; Montefiori, D. C.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.; Mathiesen, I.; Israel, Z. R.; Eldridge, J. H.; Egan, M. A.
  3. Journal of Virology. 2007, May; 81(10): 5257-5269.
  1. 11.   Antibody response to a non-conserved C-terminal part of human histone deacetylase 3 in colon cancer patients
  2. Shebzukhov, Y. V.; Koroleva, E. P.; Khlgatian, S. V.; Belousov, P. V.; Kuz'mina, K. E.; Radko, B. V.; Longpre, F.; Lagarkova, M. A.; Kadachigova, T. S.; Gurova, O. V.; Meshcheryakov, A. A.; Lichinitser, M. R.; Knuth, A.; Jager, E.; Kuprash, D. V.; Nedospasov, S. A.
  3. International Journal of Cancer. 2005, DEC 10; 117(5): 800-806.
  1. 12.   Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag
  2. Zhao, J.; Voltan, R.; Peng, B.; vis-Warren, A.; Kalyanaraman, V. S.; Alvord, W. G.; Aldrich, K.; Bernasconi, D.; Butto, S.; Cafaro, A.; Ensoli, B.; Robert-Guroff, M.
  3. Virology. 2005, NOV 10; 342(1): 1-12.
  1. 13.   Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy
  2. Shebzukhov, Y. V.; Koroleva, E. P.; Khlgatian, S. V.; Lagarkova, M. A.; Meshcheryakov, A. A.; Lichinitser, M. R.; Karbach, J.; Jager, E.; Kuprash, D. V.; Nedospasov, S. A.
  3. Immunology Letters. 2005, AUG 15; 100(1): 88-93.
  1. 14.   DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge
  2. Rosati, M.; von Gegerfelt, A.; Roth, P.; Alicea, C.; Valentin, A.; Robert-Guroff, M.; Venzon, D.; Montefiori, D. C.; Markham, P.; Felber, B. K.; Pavlakis, G. N.
  3. Journal of Virology. 2005, JUL; 79(13): 8480-8492.
  1. 15.   Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen
  2. Neelapu, S. S.; Baskar, S.; Gause, B. L.; Kobrin, C. B.; Watson, T. M.; Frye, A. R.; Pennington, R.; Harvey, L.; Jaffe, E. S.; Robb, R. J.; Popescu, M. C.; Kwak, L. W.
  3. Clinical Cancer Research. 2004, DEC 15; 10(24): 8309-8317.
  1. 16.   Insufficient production and tissue delivery of CD4(+) memory T cells in rapidly progressive simian immunodeficiency virus infection
  2. Picker, L. J.; Hagen, S. I.; Lum, R.; Reed-Inderbitzin, E. F.; Daly, L. M.; Sylwester, A. W.; Walker, J. M.; Siess, D. C.; Piatak, M.; Wang, C. X.; Allison, D. B.; Maino, V. C.; Lifson, J. D.; Kodama, T.; Axthelm, M. K.
  3. Journal of Experimental Medicine. 2004, NOV 15; 200(10): 1299-1314.
  1. 17.   Macaque dendritic cells infected with SIV-recombinant canarypox ex vivo induce SIV-specific immune responses in vivo
  2. Villamide-Herrera, L.; Ignatius, R.; Eller, M. A.; Wilkinson, K.; Griffin, C.; Mehlhop, E.; Jones, J.; Han, S. Y.; Lewis, M. G.; Parrish, S.; Vancott, T. C.; Lifson, J. D.; Schlesinger, S.; Mascola, J. R.; Pope, M.
  3. Aids Research and Human Retroviruses. 2004, AUG; 20(8): 871-884.
  1. 18.   An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS
  2. Wang, S. W.; Bertley, F. M. N.; Kozlowski, P. A.; Herrmann, L.; Manson, K.; Mazzara, G.; Piatak, M.; Johnson, R. P.; Carville, A.; Mansfield, K.; Aldovini, A.
  3. Aids Research and Human Retroviruses. 2004, AUG; 20(8): 846-859.
  1. 19.   Serosurvey of viral infections in free-ranging Namibian cheetahs (Acinonyx jubatus)
  2. Munson, L.; Marker, L.; Dubovi, E.; Spencer, J. A.; Evermann, J. F.; O'Brien, S. J.
  3. Journal of Wildlife Diseases. 2004 40(1): 23-31.
  1. 20.   CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques
  2. Verthelyi, D.; Wang, V. W.; Lifson, J. D.; Klinman, D. M.
  3. Aids. 2004 18(7): 1003-1008.
  1. 21.   Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo
  2. Fitzgerald, W.; Sylwester, A. W.; Grivel, J. C.; Lifson, J. D.; Margolis, L. B.
  3. Journal of Virology. 2004 78(13): 7061-7068.
  1. 22.   Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIVmac251 challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen
  2. Zhao, J.; Pinczewski, J.; Gomez-Roman, V. R.; Venzon, D.; Kalyanaraman, V. S.; Markham, P. D.; Aldrich, K.; Moake, M.; Montefiori, D. C.; Lou, Y. M.; Pavlakis, G. N.; Robert-Guroff, M.
  3. Journal of Virology. 2003 77(15): 8354-8365.
  1. 23.   Longitudinal follow up of SIVmac pathogenesis in rhesus macaques of Chinese origin: emergence of B cell lymphoma
  2. Ling, B.; Veazey, R. S.; Penedo, C.; Xu, K.; Lifson, J. D.; Marx, P. A.
  3. Journal of Medical Primatology. 2002 31(4-5): 154-163.
  1. 24.   Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus
  2. Kumar, A.; Mukherjee, S.; Shen, J.; Buch, S.; Li, Z.; Adany, I.; Liu, Z. Q.; Zhuge, W.; Piatak, M.; Lifson, J. D.; McClure, H. M.; Narayan, O.
  3. Virology. 2002 301(2): 189-205.
  1. 25.   HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals
  2. Moir, S.; Malaspina, A.; Ogwaro, K. M.; Donoghue, E. T.; Hallahan, C. W.; Ehler, L. A.; Liu, S. Y.; Adelsberger, J.; Lapointe, R.; Hwu, P.; Baseler, M.; Orenstein, J. M.; Chun, T. W.; Mican, J. A. M.; Fauci, A. S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2001 98(18): 10362-10367.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel